Belite Bio, Inc
NASDAQ:BLTE
62 (USD) • At close December 24, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Operating Activities: | ||||
| Net Income
| -31.632 | -12.648 | -9.666 | -5.753 |
| Depreciation & Amortization
| 0.399 | 0.198 | 0.03 | 0.017 |
| Deferred Income Tax
| -4.693 | -1.911 | 0 | -1.393 |
| Stock Based Compensation
| 3.823 | 1.483 | 1.53 | 1.363 |
| Change In Working Capital
| -2.427 | -0.491 | 0.64 | -0.069 |
| Accounts Receivables
| -0.072 | -0.032 | 0 | 0.004 |
| Inventory
| 0 | 0 | 0 | 0 |
| Accounts Payables
| 0 | 0 | 0 | 0 |
| Other Working Capital
| -2.355 | -0.459 | 0.64 | -0.073 |
| Other Non Cash Items
| 4.693 | 1.911 | -0.008 | 1.393 |
| Operating Cash Flow
| -29.837 | -11.458 | -7.474 | -4.442 |
| Investing Activities: | ||||
| Investments In Property Plant And Equipment
| -0.063 | -0.394 | -0.074 | -0.02 |
| Acquisitions Net
| 0 | 0 | 0.018 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | -0.394 | 0.018 | 0 |
| Investing Cash Flow
| -0.063 | -0.394 | -0.056 | -0.02 |
| Financing Activities: | ||||
| Debt Repayment
| 0 | 0 | 0 | 0 |
| Common Stock Issued
| 77.189 | 37.99 | -0.583 | 0.5 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 |
| Other Financing Activities
| 75.959 | -1.027 | -0.583 | 57.851 |
| Financing Cash Flow
| 75.959 | 36.963 | -0.583 | 28.059 |
| Other Information: | ||||
| Effect Of Forex Changes On Cash
| 0.009 | -0.366 | -0.161 | 0.004 |
| Net Change In Cash
| 46.068 | 24.745 | -8.274 | 23.601 |
| Cash At End Of Period
| 88.157 | 42.089 | 17.344 | 25.618 |